Contemporary human H3N2 influenza A viruses require a low threshold of suitable glycan receptors for efficient infection.
H3N2
genetic glycoengineering
influenza
poly-LacNAc
sialic acid
Journal
Glycobiology
ISSN: 1460-2423
Titre abrégé: Glycobiology
Pays: England
ID NLM: 9104124
Informations de publication
Date de publication:
30 10 2023
30 10 2023
Historique:
received:
16
02
2023
revised:
03
07
2023
accepted:
16
07
2023
medline:
9
11
2023
pubmed:
20
7
2023
entrez:
20
7
2023
Statut:
ppublish
Résumé
Recent human H3N2 influenza A viruses have evolved to employ elongated glycans terminating in α2,6-linked sialic acid as their receptors. These glycans are displayed in low abundancies by (humanized) Madin-Darby Canine Kidney cells, which are commonly employed to propagate influenza A virus, resulting in low or no viral propagation. Here, we examined whether the overexpression of the glycosyltransferases β-1,3-N-acetylglucosaminyltransferase and β-1,4-galactosyltransferase 1, which are responsible for the elongation of poly-N-acetyllactosamines (LacNAcs), would result in improved A/H3N2 propagation. Stable overexpression of β-1,3-N-acetylglucosaminyltransferase and β-1,4-galactosyltransferase 1 in Madin-Darby Canine Kidney and "humanized" Madin-Darby Canine Kidney cells was achieved by lentiviral integration and subsequent antibiotic selection and confirmed by qPCR and protein mass spectrometry experiments. Flow cytometry and glycan mass spectrometry experiments using the β-1,3-N-acetylglucosaminyltransferase and/or β-1,4-galactosyltransferase 1 knock-in cells demonstrated increased binding of viral hemagglutinins and the presence of a larger number of LacNAc repeating units, especially on "humanized" Madin-Darby Canine Kidney-β-1,3-N-acetylglucosaminyltransferase cells. An increase in the number of glycan receptors did, however, not result in a greater infection efficiency of recent human H3N2 viruses. Based on these results, we propose that H3N2 influenza A viruses require a low number of suitable glycan receptors to infect cells and that an increase in the glycan receptor display above this threshold does not result in improved infection efficiency.
Identifiants
pubmed: 37471650
pii: 7227110
doi: 10.1093/glycob/cwad060
pmc: PMC10629718
doi:
Substances chimiques
N-Acetylglucosaminyltransferases
EC 2.4.1.-
N-Acetyllactosamine Synthase
EC 2.4.1.90
Hemagglutinin Glycoproteins, Influenza Virus
0
Polysaccharides
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
784-800Subventions
Organisme : NIAID NIH HHS
ID : 75N93021C00014
Pays : United States
Organisme : NIH HHS
ID : 75N93021C00014
Pays : United States
Informations de copyright
© The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Influenza Other Respir Viruses. 2017 May;11(3):263-274
pubmed: 28164446
NPJ Vaccines. 2021 Dec 9;6(1):149
pubmed: 34887440
PLoS Pathog. 2013 Mar;9(3):e1003223
pubmed: 23516363
Nat Commun. 2018 Aug 22;9(1):3368
pubmed: 30135430
J Virol. 2019 Oct 29;93(22):
pubmed: 31484755
J Virol. 2003 Aug;77(15):8418-25
pubmed: 12857911
Nucleic Acids Res. 2022 Jan 7;50(D1):D543-D552
pubmed: 34723319
J Clin Microbiol. 2008 Jul;46(7):2189-94
pubmed: 18480230
Nat Methods. 2008 Jun;5(6):545-51
pubmed: 18454154
Am J Public Health. 2020 May;110(5):669-676
pubmed: 32267748
Virology. 2016 Jul;494:78-88
pubmed: 27085069
Cell Rep. 2019 Jun 11;27(11):3284-3294.e6
pubmed: 31189111
FEBS J. 2018 May;285(9):1611-1634
pubmed: 29542865
J Virol. 2019 May 1;93(10):
pubmed: 30842318
Virology. 1983 Jun;127(2):361-73
pubmed: 6868370
Nat Commun. 2022 Jul 13;13(1):4054
pubmed: 35831293
Proc Natl Acad Sci U S A. 2012 Dec 26;109(52):21474-9
pubmed: 23236176
Glycobiology. 2022 Mar 30;32(3):239-250
pubmed: 34939087
Nat Methods. 2018 Sep;15(9):693-696
pubmed: 30127505
Virology. 2015 Mar;477:18-31
pubmed: 25617824
Metab Eng. 2020 Sep;61:301-314
pubmed: 32663509
PLoS Pathog. 2020 Jul 8;16(7):e1008656
pubmed: 32639985
Angew Chem Int Ed Engl. 2012 May 14;51(20):4860-3
pubmed: 22505324
Proteomics. 2001 Feb;1(2):340-9
pubmed: 11680880
Nat Chem. 2019 Feb;11(2):161-169
pubmed: 30532014
J Virol. 1998 Nov;72(11):8463-71
pubmed: 9765382
Cell Host Microbe. 2018 Jun 13;23(6):809-818.e5
pubmed: 29779930
J Virol. 2010 Aug;84(16):8287-99
pubmed: 20519409
J Virol. 2008 Feb;82(4):2028-32
pubmed: 18077718
J Virol. 2022 Mar 9;96(5):e0212021
pubmed: 35044215
Sci Rep. 2022 Jul 26;12(1):12757
pubmed: 35882911
Proteomics. 2010 Jun;10(12):2330-6
pubmed: 20391534
J Biochem. 2019 Sep 1;166(3):245-258
pubmed: 31102532
J Cell Mol Med. 2017 Nov;21(11):3044-3054
pubmed: 28557288
PLoS One. 2007 Aug 08;2(8):e713
pubmed: 17684559
Science. 1996 Aug 9;273(5276):797-801
pubmed: 8670420
Nat Biotechnol. 2008 Jan;26(1):107-13
pubmed: 18176555
Nat Commun. 2021 Sep 14;12(1):5449
pubmed: 34521834
Virology. 2010 Jul 20;403(1):17-25
pubmed: 20441997
Hum Vaccin Immunother. 2018;14(8):1840-1847
pubmed: 29641358
Blood. 2004 Jan 15;103(2):664-72
pubmed: 14504081
JACS Au. 2023 Feb 17;3(3):868-878
pubmed: 37006776
J Virol. 2020 Jan 31;94(4):
pubmed: 31776280
Methods Mol Biol. 2021;2352:31-43
pubmed: 34324178
PLoS Pathog. 2010 Sep 09;6(9):e1001099
pubmed: 20844577
J Clin Microbiol. 2005 Aug;43(8):4139-46
pubmed: 16081961
Sci Adv. 2019 Feb 13;5(2):eaav2554
pubmed: 30788437
PLoS One. 2013 Nov 01;8(11):e79252
pubmed: 24223916
Trends Biotechnol. 2020 Oct;38(10):1154-1168
pubmed: 32616303
Sci Rep. 2020 Mar 24;10(1):5320
pubmed: 32210305
J Virol. 2010 Apr;84(8):3993-4001
pubmed: 20130050
Virology. 2005 Apr 10;334(2):276-83
pubmed: 15780877
J Biol Chem. 2014 Oct 10;289(41):28489-504
pubmed: 25135641
J Mol Biol. 2006 Feb 3;355(5):1143-55
pubmed: 16343533
Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9065-9
pubmed: 18550812
Microbes Infect. 2006 Feb;8(2):511-9
pubmed: 16300986
Virol J. 2007 May 09;4:42
pubmed: 17490484
Front Chem. 2018 Jul 26;6:324
pubmed: 30094234
Cell Host Microbe. 2017 Jan 11;21(1):23-34
pubmed: 28017661
Glycoconj J. 1998 Aug;15(8):737-47
pubmed: 9870349
Virology. 2001 Oct 10;289(1):74-85
pubmed: 11601919
Nature. 2001 Feb 22;409(6823):1055-60
pubmed: 11234016
J Biol Chem. 1987 Feb 5;262(4):1596-601
pubmed: 3805045
Nat Chem. 2019 Mar;11(3):229-236
pubmed: 30792508
PLoS One. 2013 Jun 21;8(6):e66325
pubmed: 23805213
Nat Microbiol. 2019 Aug;4(8):1268-1273
pubmed: 31036910
Virus Res. 2007 Nov;129(2):175-81
pubmed: 17714820
Viruses. 2021 May 01;13(5):
pubmed: 34062844
J Virol. 2014 Sep;88(18):10986-9
pubmed: 24991002
J Mol Biol. 2019 Feb 15;431(4):842-856
pubmed: 30597163
Science. 2018 Oct 12;362(6411):236-239
pubmed: 30190307
Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18153-8
pubmed: 15601777
Nucleic Acids Res. 2021 Jan 8;49(D1):D1523-D1528
pubmed: 33174597